Investing Profile

Sebastian Kreuz

InvestorVC

Executive Director / Investment Manager at Boehringer Ingelheim Venture Fund

Photo of Sebastian Kreuz, Managing Director at Boehringer Ingelheim Venture Fund

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
$3.3M - $17.0M
$8.5M
1
CompanyStageDateRound SizeTotal Raised
Centauri Therapeutics
Series AFeb 2022£24M
£24M
Co-investors: Johannes Zanzinger (Boehringer Ingelheim Venture Fund)